| ApoE | apolipoprotein E |
| BBB | blood brain barrier |
| BN | bombesin |
| BTZ | bortezomib |
| CPE | cell-penetration enhancer |
| CUR | curcumin |
| CD | cyclodextrin |
| DC | dendritic cell |
| DDS | drug delivery system |
| DEX | dextran |
| DOPE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine |
| DOX | doxorubicin |
| DPPE | 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine |
| DSPE | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine |
| DTX | docetaxel |
| EDAC | 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide |
| EGFR | epidermal growth factor receptor |
| EPR | enhanced permeability and retention |
| FA | folic acid |
| FR | folate receptor |
| 5-FU | 5-fluorouracil |
| FZD10 | frizzled 10 protein |
| GEM | gemcitabine |
| HA | hyaluronic acid |
| HEGFR | human epidermal growth factor receptor |
| HPβ-CD | 2-(hydroxypropyl)-β-cyclodextrin |
| INS | insulin |
| Lf | lactoferrin |
| mAb(s) | monoclonal antibody(ies) |
| MDR | multidrug resistance |
| MTX | methotrexate |
| NB(s) | nanobubble(s) |
| NP(s) | nanoparticle(s) |
| PCL | poly(ε-caprolactone) |
| PDAC | pancreatic adenocarcinoma |
| PEG | polyethylene glycol |
| PEI | polyethyleneimine |
| PLGA | poly lactic-co-glycolic acid |
| PLA | poly lactic acid |
| PSMA | prostate-specific membrane antigen |
| PTX | paclitaxel |
| SLN(s) | solid lipid nanoparticle(s) |
| SQ | squalene |
| SVA(s) | supramolecular vesicular aggregate(s) |
| T3 | thyroid hormone triiodothyronine |
| Tf | transferrin |
| TfR | Tf receptor |
| TSH | thyroid-stimulating hormone |
| US | ultrasounds |
| UT | urotensin-II |
| VLDL | very low-density lipoprotein |